Systemic inflammation and residual viraemia in HIV-positive adults on protease inhibitor monotherapy: a cross-sectional study
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Systemic inflammation and residual viraemia in HIV-positive adults on protease inhibitor monotherapy: a cross-sectional study
Authors
Keywords
PI monotherapy, Residual viraemia, Systemic inflammation
Journal
BMC INFECTIOUS DISEASES
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-03-20
DOI
10.1186/s12879-015-0889-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Inflammatory, procoagulant markers and HIV residual viremia in patients receiving protease inhibitor monotherapy or triple drug therapy: a cross-sectional study
- (2014) Miriam Estébanez et al. BMC INFECTIOUS DISEASES
- Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation
- (2014) Berta Torres et al. Journal of the International AIDS Society
- Predicting risk of cancer during HIV infection
- (2013) Álvaro H. Borges et al. AIDS
- Human immunodeficiency virus, hepatitis C, and inflammatory biomarkers in individuals with alcohol problems: a cross-sectional study
- (2013) Kaku A Armah et al. BMC INFECTIOUS DISEASES
- Associations of Inflammatory Markers With AIDS and Non-AIDS Clinical Events After Initiation of Antiretroviral Therapy
- (2013) Grace A. McComsey et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Circulating interleukin-6 levels correlate with residual HIV viraemia and markers of immune dysfunction in treatment-controlled HIV-infected patients
- (2012) Jean-Philippe Bastard et al. ANTIVIRAL THERAPY
- Long-Term Efficacy and Safety Profile of Rilonacept in the Treatment of Cryopryin-Associated Periodic Syndromes: Results of a 72-Week Open-Label Extension Study
- (2012) Hal M. Hoffman et al. CLINICAL THERAPEUTICS
- Low-Level HIV Viremia Is Associated With Microbial Translocation and Inflammation
- (2012) Sergio Reus et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- Serum Amyloid A Circulating Levels and Disease Activity in Patients with Juvenile Idiopathic Arthritis
- (2012) Luca Cantarini et al. YONSEI MEDICAL JOURNAL
- Serum amyloid A in atherosclerosis
- (2011) Victoria L. King et al. CURRENT OPINION IN LIPIDOLOGY
- Treatment simplification in HIV-infected adults as a strategy to prevent toxicity, improve adherence, quality of life and decrease healthcare costs
- (2011) Jean Nachega et al. Patient Preference and Adherence
- Inflammation and Mortality in HIV-Infected Adults: Analysis of the FRAM Study Cohort
- (2010) Phyllis C Tien et al. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES
- The Mitochondrion — A Trojan Horse That Kicks Off Inflammation?
- (2010) Angelo A. Manfredi et al. NEW ENGLAND JOURNAL OF MEDICINE
- Role of biomarkers in predicting CVD risk in the setting of HIV infection?
- (2010) Signe W Worm et al. Current Opinion in HIV and AIDS
- The MONET trial: darunavir/ritonavir with or without nucleoside analogues, for patients with HIV RNA below 50 copies/ml
- (2009) Jose R Arribas et al. AIDS
- Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study
- (2009) Signe Westring Worm et al. JOURNAL OF INFECTIOUS DISEASES
- Ultrasensitive assessment of residual HIV viraemia in HAART-treated patients with persistently undetectable plasma HIV-RNA: A cross-sectional evaluation
- (2009) Stefano Bonora et al. JOURNAL OF MEDICAL VIROLOGY
- Long-term (4 years) efficacy of lopinavir/ritonavir monotherapy for maintenance of HIV suppression
- (2008) F. Pulido et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More